Form 8-K - Current report:
SEC Accession No. 0001437749-21-002896
Filing Date
2021-02-16
Accepted
2021-02-16 08:10:09
Documents
3
Period of Report
2021-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20210215_8k.htm 8-K 24103
2 EXHIBIT 99.1 ex_226666.htm EX-99.1 14721
3 d01.jpg GRAPHIC 5749
  Complete submission text file 0001437749-21-002896.txt   48257
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 21632682
SIC: 2834 Pharmaceutical Preparations